Skip to main content
. 2022 Apr 14;13:874176. doi: 10.3389/fphar.2022.874176

FIGURE 2.

FIGURE 2

Growth curves of the total population of the zoliflodacin-resistant Neisseria gonorrhoeae SE600/18-D429N mutant (containing GyrB S467N amino acid substitution plus an in vitro selected D429N substitution), in the dose-range Hollow Fiber Infection Model experiment simulating zoliflodacin single oral dose of 2 (A), 3 (B), 4 (C), and 6 g (D) and followed for 7 days are shown (black solid lines). The total growth of population with increased resistance (red lines) on the zoliflodacin-containing plates (2 × MIC) and total growth of the untreated control (C; black dashed line) are also shown for each treatment.